Can Mounjaro Cause Bleeding — and Should You Be Concerned?

The myth: that Mounjaro is known to cause bleeding

A question our prescribers hear most weeks, in one form or another, is whether tirzepatide thins the blood or triggers bleeding. The short answer is that it does not, and this matters because the misconception can cause unnecessary worry, or, in the opposite direction, lead people to dismiss a symptom that genuinely warrants attention.

The tirzepatide SmPC and the NICE appraisal TA1026 do not flag bleeding as a recognised adverse effect. The SURMOUNT-1 trial, which followed thousands of adults over 72 weeks at doses up to 15 mg, did not identify it as a signal. That is reassuring. What the research does show is a GI-led side-effect profile (nausea, reflux, constipation, loose stools) particularly around dose changes. None of those are bleeding, though it is worth knowing what to look out for (see below).

The confusion probably arises from three separate things arriving in the same conversation: menstrual changes, the known GI effects, and general online noise from people conflating different medicines. Separating them makes the picture much clearer.

Menstrual bleeding and cycle changes on Mounjaro

This is where most of the real-world reports cluster. Women starting tirzepatide sometimes notice that their periods arrive earlier, later, heavier or lighter than usual, particularly in the first few months. This is covered in more detail on our Mounjaro and period changes page, but the key point here is mechanism: it is almost certainly driven by the metabolic and hormonal shifts that accompany meaningful weight loss, not by tirzepatide acting directly on reproductive tissue.

Oestrogen is stored in adipose tissue. As body fat reduces, circulating oestrogen levels can shift, and the hypothalamic-pituitary-ovarian axis (the hormonal loop that governs the cycle) responds. Similar cycle disruption is reported after bariatric surgery and with other effective weight-loss interventions. It tends to settle as weight stabilises, though every person's cycle is different.

Women using HRT alongside Mounjaro may notice different patterns again, partly because NHS England advises considering transdermal HRT during tirzepatide treatment due to potential changes in oral absorption. If bleeding is heavier than a normal period, irregular in a way that feels new, or accompanied by pain, that is a conversation for a GP, not something to wait out.

Separately, women who want to understand possible vaginal bleeding on Mounjaro in contexts beyond the period will find specific detail there.

GI symptoms that can be confused with internal bleeding

Gastrointestinal side effects are the most consistently reported effects of tirzepatide, and some of them can, in unusual circumstances, be mistaken for or precede something more serious. Dark or tarry stools, vomiting blood, or blood visible in the stool are not expected effects of Mounjaro and should be treated as a reason to get same-day medical attention, from a GP, urgent care, or 999 if severe.

More commonly, people notice that nausea or reflux-style discomfort can occasionally cause minor irritation of the oesophagus, particularly if vomiting is frequent during the early weeks of treatment. That can cause small amounts of blood to appear in vomit. It is still something to report to a clinician, but it is a different situation from internal haemorrhage.

The MHRA Yellow Card scheme exists precisely for this kind of reporting: if you experience an unexpected symptom while on a licensed medicine, submitting a report helps build the national safety picture. Our Mounjaro and bleeding overview page covers the full range of symptom types and what each one means in practice.

When bleeding is a reason to contact a clinician

A few situations call for prompt action rather than watchful waiting. If you notice blood in your stool, black or tarry stools, or blood when you vomit, seek medical help the same day. Heavy or prolonged vaginal bleeding that does not follow the pattern of a normal (if disrupted) period should also be discussed with a GP. Bleeding gums are a separate question, our page on gum bleeding and Mounjaro goes into the evidence there.

People taking anticoagulants such as warfarin or apixaban should make sure their prescriber knows before starting tirzepatide. Tirzepatide slows gastric emptying, which can affect how oral medicines are absorbed and, by extension, how anticoagulant levels behave. That is a clinical conversation, not a barrier, but it is one to have upfront. A prescriber with a full medication history can assess it properly. If you are already on tirzepatide and have started a new medicine, let your GP or pharmacist know.

For anyone thinking about starting treatment and wanting to understand the full picture, our free consultation connects you with a GPhC-registered prescriber who reviews your health history before any prescription is issued.